These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 24422369

  • 1. An update on thalassemia intermedia.
    Maakaron JE, Cappellini MD, Taher AT.
    J Med Liban; 2013; 61(3):175-82. PubMed ID: 24422369
    [Abstract] [Full Text] [Related]

  • 2. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD, Motta I.
    Hematology Am Soc Hematol Educ Program; 2017 Dec 08; 2017(1):278-283. PubMed ID: 29222267
    [Abstract] [Full Text] [Related]

  • 3. [Current management of thalassemia intermedia].
    Thuret I.
    Transfus Clin Biol; 2014 Nov 08; 21(4-5):143-9. PubMed ID: 25282488
    [Abstract] [Full Text] [Related]

  • 4. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J.
    Int J Hematol; 2018 Jul 08; 108(1):5-21. PubMed ID: 29380178
    [Abstract] [Full Text] [Related]

  • 5. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A, Kahale M, Sbeiti N, Cappellini MD, Taher AT, Koussa S, Nasr TA, Musallam KM, Abbas HA, Porter JB.
    Pediatr Blood Cancer; 2017 Jan 08; 64(1):188-196. PubMed ID: 27576370
    [Abstract] [Full Text] [Related]

  • 6. [Overview of new approaches to β-thalassemia treatment].
    Guo XF, Han L, Zhang XC, Zhang HH, Liu J.
    Sheng Li Xue Bao; 2024 Jun 25; 76(3):496-506. PubMed ID: 38939943
    [Abstract] [Full Text] [Related]

  • 7. The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia.
    Nyffenegger N, Flace A, Doucerain C, Dürrenberger F, Manolova V.
    Int J Mol Sci; 2021 Jan 16; 22(2):. PubMed ID: 33467196
    [Abstract] [Full Text] [Related]

  • 8. Revisiting beta thalassemia intermedia: past, present, and future prospects.
    Ben Salah N, Bou-Fakhredin R, Mellouli F, Taher AT.
    Hematology; 2017 Dec 16; 22(10):607-616. PubMed ID: 28589785
    [Abstract] [Full Text] [Related]

  • 9. Beta-thalassemia.
    Rund D, Rachmilewitz E.
    N Engl J Med; 2005 Sep 15; 353(11):1135-46. PubMed ID: 16162884
    [No Abstract] [Full Text] [Related]

  • 10. 2021 update on clinical trials in β-thalassemia.
    Musallam KM, Bou-Fakhredin R, Cappellini MD, Taher AT.
    Am J Hematol; 2021 Nov 01; 96(11):1518-1531. PubMed ID: 34347889
    [Abstract] [Full Text] [Related]

  • 11. Retinal abnormalities in β-thalassemia major.
    Bhoiwala DL, Dunaief JL.
    Surv Ophthalmol; 2016 Nov 01; 61(1):33-50. PubMed ID: 26325202
    [Abstract] [Full Text] [Related]

  • 12. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
    Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A.
    Pediatr Hematol Oncol; 2014 Oct 01; 31(7):583-96. PubMed ID: 25247665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New strategies in the treatment of the thalassemias.
    Schrier SL, Angelucci E.
    Annu Rev Med; 2005 Oct 01; 56():157-71. PubMed ID: 15660507
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
    Kontoghiorghe CN, Kontoghiorghes GJ.
    Drug Des Devel Ther; 2016 Oct 01; 10():465-81. PubMed ID: 26893541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.
    Angelucci E, Pilo F.
    Ann N Y Acad Sci; 2016 Mar 01; 1368(1):115-21. PubMed ID: 26999450
    [Abstract] [Full Text] [Related]

  • 19. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
    Saliba AN, El Rassi F, Taher AT.
    Expert Rev Hematol; 2016 Mar 01; 9(2):151-68. PubMed ID: 26613264
    [Abstract] [Full Text] [Related]

  • 20. Optimal management of β thalassaemia intermedia.
    Taher AT, Musallam KM, Cappellini MD, Weatherall DJ.
    Br J Haematol; 2011 Mar 01; 152(5):512-23. PubMed ID: 21250971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.